Study: Pfizer vaccine 94% effective at preventing symptomatic infections
The study found a 94% drop in symptomatic infections and a 92% drop in serious cases of the disease among those vaccinated.
The study found a 94% drop in symptomatic infections and a 92% drop in serious cases of the disease among those vaccinated.